We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-0.16%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.7B
AUM Growth
+$566M
Cap. Flow
+$690M
Cap. Flow %
5.42%
Top 10 Hldgs %
16.23%
Holding
2,054
New
761
Increased
358
Reduced
482
Closed
414

Sector Composition

Rank Sector Weight
1 Healthcare 25.14%
2 Consumer Discretionary 19.28%
3 Technology 12.46%
4 Industrials 8.42%
5 Financials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCEC
1526
Capital Clean Energy Carriers
CCEC
$1.4B
$38K ﹤0.01%
+3,515
New +$37.9K
HARP
1527
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$38K ﹤0.01%
+275
New +$38.7K
EVLO
1528
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$38K ﹤0.01%
+310
New +$42.6K
ALBO
1529
DELISTED
Albireo Pharma Inc
ALBO
$38K ﹤0.01%
+1,883
New +$48.7K
NTGN
1530
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$38K ﹤0.01%
+21,809
New +$66.4K
CRD.A icon
1531
Crawford & Co Class A
CRD.A
$536M
$37K ﹤0.01%
+3,406
New +$34.9K
MGTX icon
1532
MeiraGTx Holdings
MGTX
$1.09B
$37K ﹤0.01%
+2,303
New +$53.6K
QTTB icon
1533
Q32 Bio
QTTB
$450M
$37K ﹤0.01%
114
-733
-87% -$249K
MTW icon
1534
Manitowoc
MTW
$516M
$36K ﹤0.01%
+2,894
New +$43.7K
MYRG icon
1535
MYR Group
MYRG
$5.9B
$36K ﹤0.01%
+1,145
New +$36.9K
BR icon
1536
Broadridge
BR
$17.2B
$35K ﹤0.01%
284
-30,448
-99% -$3.92M
NHI icon
1537
National Health Investors
NHI
$3.9B
$35K ﹤0.01%
428
-86,462
-100% -$7.04M
PCH
1538
DELISTED
PotlatchDeltic
PCH
$35K ﹤0.01%
+856
New +$33.2K
RP
1539
DELISTED
RealPage, Inc.
RP
$35K ﹤0.01%
563
-32,638
-98% -$2.04M
STML
1540
DELISTED
Stemline Therapeutics, Inc.
STML
$35K ﹤0.01%
+3,354
New +$43.9K
HXL icon
1541
Hexcel
HXL
$8.32B
$34K ﹤0.01%
+419
New +$34.2K
IONS icon
1542
Ionis Pharmaceuticals
IONS
$9.35B
$34K ﹤0.01%
+561
New +$36.6K
TLYS icon
1543
Tilly's
TLYS
$115M
$34K ﹤0.01%
+3,625
New +$32K
WLDN icon
1544
Willdan Group
WLDN
$1.1B
$34K ﹤0.01%
+981
New +$35K
GSH
1545
DELISTED
Guangshen Railway Co. Ltd
GSH
$34K ﹤0.01%
+2,129
New +$34.7K
CSTE icon
1546
Caesarstone
CSTE
$72.3M
$33K ﹤0.01%
+2,003
New +$30.5K
SBH icon
1547
Sally Beauty Holdings
SBH
$1.4B
$33K ﹤0.01%
+2,217
New +$29K
USX
1548
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$33K ﹤0.01%
+6,787
New +$30.9K
CVET
1549
DELISTED
Covetrus, Inc. Common Stock
CVET
$33K ﹤0.01%
+2,797
New +$51.8K
NVTR
1550
DELISTED
Nuvectra Corporation Common Stock
NVTR
$33K ﹤0.01%
+23,937
New +$46.9K

Similar funds

Marshall Wace's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace held 2,054 positions worth $12.7B, up 4.7% from $12.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $690M of net new capital in Q3 2019, opening 761 new positions and adding to 358 existing holdings. Its largest new stake was Restaurant Brands International: 1,898,808 shares worth $135M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Amazon, an estimated $141M trimmed.

  • Marshall Wace's largest Q3 2019 buy was Restaurant Brands International: 1,898,808 shares worth $135M.
  • Marshall Wace added most to Danaher in Q3 2019, an estimated $74.1M increase.
  • Marshall Wace's biggest Q3 2019 reduction was Amazon, cutting an estimated $141M.
  • Marshall Wace fully exited Red Hat Inc in Q3 2019, selling an estimated $53.6M.
  • Marshall Wace's ten largest holdings make up 16% of its $12.7B portfolio in Q3 2019.
  • Marshall Wace opened 761 new positions and closed 414 in Q3 2019.
  • Marshall Wace's portfolio value rose 4.7% quarter-over-quarter to $12.7B.

Based on Marshall Wace's 13F filing for Q3 2019, filed 14 Nov 2019.